Edward White
Stock Analyst at HC Wainwright & Co.
(1.47)
# 3,574
Out of 5,241 analysts
338
Total ratings
29.97%
Success rate
-8.95%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $14.87 | +121.92% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $5.70 | +198.25% | 41 | Apr 15, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $2.93 | +411.95% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $3.56 | +68.54% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $0.48 | +3,233.33% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.61 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $19.91 | +301.81% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $1.44 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $9.22 | +116.92% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $4.36 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $3.24 | +393.83% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $7.47 | +234.67% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.50 | +220.00% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $16.16 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $7.50 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $39.48 | +39.31% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $19.41 | +162.75% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $6.81 | +2.79% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $7.14 | +684.31% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $101 → $52 | - | - | 4 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.76 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $28.32 | +5.93% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.73 | +593.64% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $14.87
Upside: +121.92%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $5.70
Upside: +198.25%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $2.93
Upside: +411.95%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $3.56
Upside: +68.54%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $0.48
Upside: +3,233.33%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.61
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $19.91
Upside: +301.81%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.44
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $9.22
Upside: +116.92%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.36
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $3.24
Upside: +393.83%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $7.47
Upside: +234.67%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $2.50
Upside: +220.00%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $16.16
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $7.50
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $39.48
Upside: +39.31%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $19.41
Upside: +162.75%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $6.81
Upside: +2.79%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $7.14
Upside: +684.31%
Aug 5, 2022
Downgrades: Neutral
Price Target: $101 → $52
Current: -
Upside: -
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $0.76
Upside: -
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $28.32
Upside: +5.93%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.73
Upside: +593.64%